HG
About
HLB Group creates a management network to establish the conditions for the manufacture, sale, and discovery of new medications. They create rivoceranib, the cancer medicine, and "UNITE," a platform for the next generation of immunotherapy vaccines against cancer and allergies.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 6 investors are based in Ulsan, Kyongsang-bukto, South Korea.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- Ulsan, South Korea
Contact Information
linkedin.com/in/••••••••
Find more investors like HLB
Search Investors